Selected References:
- Bauer RL, et al. 2017. Use of transdermal selegiline in pregnancy and lactation: a case report. Psychosomatics, 58(4):450-452.
- Hagell P, et al. 1998. Pregnancy in Parkinson’s disease: a review of the literature and a case report. Mov Disord, 13(1):34-38.
- Kupsch A, Oertel WH. 1998. Selegiline, pregnancy, and Parkinson’s disease. Mov Disord, 13(1):175-176.
- Selegiline Drug Labels. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021479s010lbl.pdf and https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b891bd9f-fdb8-4862-89c5-ecdd700398a3&audience=consumer.
- Shimazu H, et al. 1995. [Study on oral administration of FPF 1100 prior to pregnancy, pregnancy, and lactation period in rats.] Yakuri To Chiryo, 23(1):57-70.
- Whitaker-Azmitia PM, et al. 1994. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology, 11(2):125-132.
